Who
Patrick J. Balthrop
Director
Company insider
Files Form 4 as: Director, MaxCyte; Director, Oxford Immunotec Global; Director, Personalis; President & CEO, Luminex.
In numbers
- Trades disclosed
- 111
- Buys
- 3
- Sells
- 10
- Bought
- $235K
- Sold
- $6.1M
- Companies
- 4
- Companies where not an officer
- 3
- First trade
- 5 Apr 2006
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | MXCT MaxCyteLife-science tools | SEC FORM 4 Code A | —30,421 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | MXCT MaxCyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —49,579 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | MXCT MaxCyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —49,579 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | MXCT MaxCyteLife-science tools | SEC FORM 4 Code A | —30,421 at $0.00 | filing |
| 18 Jun 2025filed 23 Jun 2025 | MXCT MaxCyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —50,790 at $0.00 | filing |
| 18 Jun 2025filed 23 Jun 2025 | MXCT MaxCyteLife-science tools | SEC FORM 4 Code A | —29,210 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | MXCT MaxCyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —40,701 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | MXCT MaxCyteLife-science tools | SEC FORM 4 Code A | —21,367 at $0.00 | filing |
| 22 Jun 2023filed 23 Jun 2023 | MXCT MaxCyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 30 Nov 2022filed 1 Dec 2022 | MXCT MaxCyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 8 Mar 2021filed 12 Mar 2021 | Oxford Immunotec Global | SEC FORM 4 Code D | $178K8,081 at $22.00 | filing |
| 8 Mar 2021filed 12 Mar 2021 | Oxford Immunotec Globaloption or derivative | SEC FORM 4 Code D | $39K3,728 at $10.38 | filing |
| 8 Mar 2021filed 12 Mar 2021 | Oxford Immunotec Globaloption or derivative | SEC FORM 4 Code D | $155K14,914 at $10.38 | filing |
| 8 Mar 2021filed 12 Mar 2021 | Oxford Immunotec Globaloption or derivative | SEC FORM 4 Code D | $100K7,457 at $13.35 | filing |
| 8 Mar 2021filed 12 Mar 2021 | Oxford Immunotec Globaloption or derivative | SEC FORM 4 Code D | $56K7,457 at $7.54 | filing |
| 8 Mar 2021filed 12 Mar 2021 | Oxford Immunotec Globaloption or derivative | SEC FORM 4 Code D | $56K7,457 at $7.51 | filing |
| 8 Mar 2021filed 12 Mar 2021 | Oxford Immunotec Globaloption or derivative | SEC FORM 4 Code D | $56K7,457 at $7.56 | filing |
| 8 Mar 2021filed 12 Mar 2021 | Oxford Immunotec Globaloption or derivative | SEC FORM 4 Code D | $86K9,494 at $9.04 | filing |
| 24 Jun 2020filed 26 Jun 2020 | Oxford Immunotec Globaloption or derivative | SEC FORM 4 Code A | —9,494 at $0.00 | filing |
| 24 Jun 2020filed 26 Jun 2020 | Oxford Immunotec Global | SEC FORM 4 Code A | —4,081 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.